|
HS Code |
758169 |
| Product Name | Antistrept |
| Active Ingredient | Streptokinase |
| Manufacturer | Everest Pharmaceuticals Ltd. |
| Dosage Form | Lyophilized powder for injection |
| Strength | 1,500,000 IU per vial |
| Route Of Administration | Intravenous |
| Indications | Acute myocardial infarction, pulmonary embolism, deep vein thrombosis |
| Storage Temperature | 2-8°C |
| Packaging | Single-use vial with sterile water for injection |
| Prescription Status | Prescription only |
| Mechanism Of Action | Promotes fibrinolysis by converting plasminogen to plasmin |
As an accredited Antistrept factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Antistrept is packaged in a white 10 mL vial with blue accents, clearly labeled with product name, dosage, and manufacturer details. |
| Shipping | Antistrept is shipped in tightly sealed, approved chemical containers to prevent leakage and contamination. The packaging complies with international safety standards for hazardous materials. During transit, it is kept at controlled temperatures and labeled with hazard classifications. Appropriate documentation and handling instructions are provided for safe and efficient delivery. |
| Storage | Antistrept should be stored in a cool, dry place, away from direct sunlight and moisture. Keep the container tightly closed and store it at a temperature between 2°C and 8°C (refrigerated). Ensure it is out of reach of children and unauthorized personnel. Do not freeze. Follow all safety and handling guidelines provided by the manufacturer for optimal stability and efficacy. |
Competitive Antistrept prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Our team at the manufacturing facility has spent years developing Antistrept, focussing on the real needs faced by food processors, pharmaceutical manufacturers, and animal agriculture. In a world where quality standards keep getting stricter and the market keeps asking for safer products, our work with Antistrept represents practical experience and direct answers rather than empty claims.
We produce Antistrept under the model number AS550. This formulation delivers a consistently measured concentration designed to target Streptococci and related Gram-positive bacteria. We standardize each batch from fermentation to finish, following a protocol refined over hundreds of production cycles. By controlling temperature, pH, and nutrient feeds in the bioreactor, we yield a stable product, always meeting test limits for microbial purity and chemical contaminants. There aren’t abrupt shifts or guesswork along the way.
Each lot of Antistrept-AS550 ships with a full analytical certificate. Potency falls within the range of 550,000 IU per gram—this is not just a label claim but a value we confirm through in-house and third-party labs before release. As the manufacturer, we place raw material traceability at the core of our operation. All input sugars, peptones, and minerals get tested on receipt. Our operators and chemists maintain a closed-loop system, limiting cross-contamination and product variability. We don’t hide behind generic test sheets from resellers. The real fingerprint comes from our fermenters, from our own quality team’s work in the lab, and it’s tied to a single production run.
We maintain residual solvent levels far below published toxic thresholds, and we audit our water quality just as we do our finished goods. Finished Antistrept arrives as a free-flowing powder, with moisture content capped under 4%. Thermal stability matters—our storage protocol relies on documented, real-world stress tests rather than just theoretical storage claims. Over years of warehouse management, we have seen how product exposed to fluctuating humidity or temperature struggles to stay effective. Direct feedback from our users has made us resolve shipping and logistics problems that can undermine quality.
Most customers turn to Antistrept in fermentation and animal feed. In dairy, it serves as a specialized hurdle against Streptococcus-induced spoilage. Few synthetic alternatives act so selectively and maintain compatibility with lactic acid bacteria needed for cheese and yogurt. Feed manufacturers working with us often use Antistrept as part of their broader strategy to manage animal health, especially in the face of tightening antibiotic controls and increasing resistance pressure. In pharmaceutical fermentation, we find Antistrept useful for protecting production cultures from accidental contamination, especially for sensitive processes like penicillin or vitamin production.
With over a decade on the shop floor, we have watched trends shift from unregulated antibiotic addition to more precise, data-driven dosing. Users appreciate how Antistrept can clear the necessary regulatory hurdles, supported by full origin documentation and real stability samples, not just paperwork. Fewer buyers expect a one-size-fits-all solution—so we have invested in blending, custom packaging, and live tech support that answers batch-specific questions. We know every user’s system is slightly different, and we help integrate our product with their existing protocols instead of forcing them to overhaul everything at once.
We don’t rebrand commodity powders shipped from whatever country happens to be cheapest this month. Each batch leaving our facility is the clear outcome of long-term investment in process validation and repeatable manufacturing. Unlike platforms reselling indistinguishable powders, we get direct calls when users find a question or a process isn’t working. We don’t send them back into a global supply chain black hole; we investigate based on firsthand technical knowledge.
Many products on the market sit in warehouses for months, their chain of custody broken and their documentation lost. By manufacturing and packing locally, we guarantee that cold-chain and humidity controls actually take place. Antistrept doesn’t go through repackaging stages, so there are no extra excipients or hidden contaminants from bulk handlers. The final product you receive contains only the ingredients described on the batch release.
Generic competitors repackage bulk materials and rarely have real-time access to the production plant or the original fermentation runs. Often, buyers receive just a certificate of analysis with incomplete traceability. Our team backs every box of Antistrept with a lab history and implementation support. If a client experiences an unexpected microbiological profile, we work directly with them to comb through test results—from raw ingredient screening to finished product titration.
Unlike resellers who adjust prices based mainly on shipping rates, we focus on cost savings rooted in process yield and reduced downtime at the client’s plant. Lower batch-to-batch variation means fewer unplanned troubleshooting cycles. Our ongoing partnerships with downstream users feed directly into process improvement; if a food manufacturer logs recurring spoilage, we help with targeted root cause analysis. Trust gets built in the open, not behind a wall of stock photos and repeat sales pitches.
Supply chain jitters make headlines, but real manufacturing security comes from diversified sourcing and local stockpiles of raw inputs. We maintain partnership contracts with growers and bulk ingredient vendors whom we have audited personally. Procurement doesn’t just mean the lowest spot price—it means consistent delivery and responsible stewardship. We’ve had years with drought, labor shortages, regulatory curveballs, and we still find ways to keep our production schedule steady. This stability matters to feed integrators, dairy processors, and pharmaceutical fermenters who can’t afford a surprise disruption.
Each production campaign is mapped against projected demand. If a new regulation hits, or disease cycles shift, we adjust. We work directly with customers’ purchasing teams to anticipate needs for Antistrept months ahead to avoid the scramble and risk that arises from last-minute rush orders. The global market for microbial control products doesn’t reward those who try to time the market. Instead, trust comes from predictable delivery, honest troubleshooting, and steady technical communication.
In our factory, Antistrept is manufactured under ISO 9001 and HACCP principles, but meeting paperwork requirements never stands in for actual risk control. Plant staff follow a combined written and practical safety regimen. Batches that don’t pass sterility or chemical profile checks never leave the production floor—we destroy or rework them under a controlled destruction protocol, fully documented from QA signoff to final disposal. We have faced visitations from government auditors, private certifiers, and partners from food and pharmaceutical multinationals. Our documentation is open to these eyes and our staff can produce answers directly, not from a script.
Experienced users frequently ask about antibiotic resistance and legal compliance. We address these concerns in real conversations, often giving supporting data from field or pilot trials. Many alternatives claim “natural” or “pure” status but lack residue data on finished feeds or food. We operate in a sector under the magnifying glass, and we share our experience proactively so that buyers avoid risk and build defensible process documentation.
Our technical staff aren’t isolated from plant operations or forced to rely solely on abstract product data. More than once, we have worked alongside client QC teams, tracing error patterns and identifying incompatibilities with existing process chemicals. For users working with sensitive starter cultures, we’ve developed troubleshooting guides and compatibility charts—based on five years’ accumulated reports, not just theory or marketing.
Users in animal feed, for example, often want to know how Antistrept interacts with complex premixes or pelletizing steps. During plant trials, we monitor results, adjust recommendations, and visit sites to see actual process flows. If user data points toward an unforeseen contamination risk, we don’t stop at generic solutions; we work with nutritionists, plant engineers, and lab staff to solve technical and compliance issues before they cascade into broader problems.
Food and pharma clients cite ease of integration as a real benefit—once process and dosing are optimized, Antistrept fits into documented CCPs and pass-through steps. More important, we support long-term users not just at the start but as their plants scale up or regulations evolve.
Over more than a decade, Antistrept has contributed to improvements in shelf-life, reduced spoilage, and lowered product recalls across markets. We don’t rely on isolated case studies from unrelated geographies. Instead, our data covers real-world production runs audited by independent labs and validated inside client factories. Users have found Antistrept critical during periods of elevated contamination risk—such as seasonal changes in raw milk bacterial loads or shifts in animal health status.
Where clients have shifted away from undifferentiated antibiotic blends to controlled-dosing with Antistrept, we have tracked reductions in off-spec results and flagged costs. Many users initially come to us with skepticism, burned before by unreliable generic products or failed import orders. Direct access to technical backup and real-time troubleshooting has helped us rebuild faith in reliable microbial control.
The feedback that matters most comes from those who see less downtime and smoother audits. Feedback loops running from user site back to our plant lead to continuous improvement. This is not just a sales pitch—it’s a real way to stay ahead of both regulatory and microbial risks.
Science and standards never stand still. Every production campaign is an experiment and a chance to refine process control. Each new batch of Antistrept incorporates lessons from recent QC and development trials. Our manufacturing protocols evolve in response to user feedback—if plant engineers find a better way to blend or apply the product, we adapt and share those lessons across our user base.
Antistrept isn’t a relic or a commodity that stands still. Product upgrades roll out informed by real data—faster analysis tools, fresher batches, tighter control of trace detections. We see global pressure mounting for alternatives to broad-spectrum antibiotics, and have invested in pathway research beyond current regulations. This keeps our production and QC teams committed to the next level of technical and regulatory requirements, not just meeting today’s bar.
We remind every prospective customer: our role doesn’t end at delivery. As a direct manufacturer, we share not only the technical details but also the day-by-day work of keeping your process secure and your end users safe. Whether you work in milk processing, feed integration, or pharmaceutical fermentation, our team brings experience to your practical challenges, not just access to supply.
The market is crowded with resellers promising easy fixes, but most lack the infrastructure and history to follow through on support or innovation. We have learned that long-term adoption of microbial control solutions—in a business where one recall or quality failure can make headlines—depends on openness, technical partnership, and a willingness to respond when things go wrong. We’ve built Antistrept as a direct answer to this reality, and we invite every customer to lean on our experience and honest approach, not just our product label.